<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00897273</url>
  </required_header>
  <id_info>
    <org_study_id>J0729</org_study_id>
    <secondary_id>P30CA006973</secondary_id>
    <secondary_id>NA_00009472</secondary_id>
    <secondary_id>JHOC-J0729</secondary_id>
    <secondary_id>CDR0000554422</secondary_id>
    <nct_id>NCT00897273</nct_id>
  </id_info>
  <brief_title>Oral HPV Infection in Young Men</brief_title>
  <official_title>Human Papillomavirus Infection of the Mouth in Young Men and Risk Factors for Oropharyngeal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</source>
  <brief_summary>
    <textblock>
      RATIONALE: Gathering information about human papillomavirus infection of the mouth in young
      men may help doctors learn more about risk factors for oropharyngeal cancer.

      PURPOSE: This research study is assessing human papillomavirus infection of the mouth in
      young men and risk factors for oropharyngeal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Estimate the prevalence of oral human papillomavirus (HPV) type 16, 18, 6, or 11
           infection in young adult men.

        -  Assess the independent effect of distinct sexual practices, including kissing, oral sex,
           and vaginal intercourse, on oral HPV prevalence.

        -  Estimate the 6-month incidence of HPV infection in this study population.

      OUTLINE: Participants are assessed for oral human papillomavirus virus (HPV) infection (i.e.,
      types 16, 18, 6, and 11) and for known or potential risk factors associated with the
      infection, including sexual behavior (e.g., kissing, performing oral sex, or vaginal
      intercourse), demographic characteristics (e.g., age or race), and history of HPV or other
      sexually transmitted infections. Prior exposure to HPV vaccine is also assessed.

      Oral rinse samples are collected from participants at baseline and at 6 months for detection
      of HPV genomic DNA in oral exfoliated cells. Baseline serum samples are also collected.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">May 5, 2009</completion_date>
  <primary_completion_date type="Actual">May 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of an oral human papillomavirus (HPV) type 16, 18, 6 or 11 infection</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of oral HPV infection by any of 37 HPV types</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">500</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Infection</condition>
  <condition>Precancerous Condition</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>comparative genomic hybridization</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>gene expression analysis</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>study of socioeconomic and demographic variables</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>evaluation of cancer risk factors</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>study of high risk factors</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Laboratory Methods:

      Oral rinse sample:

      Standard, well-validated assays will be used to detect HPV genomic DNA in oral exfoliated
      cells from the Scope oral rinse sample.

      Serum sample:

      Standard laboratory assays will be used to detect antibodies to HPV16 L1 viral capsid
      protein.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A convenience sample of 500 men recruited from Baltimore-area college health centers (Johns
        Hopkins University, University of Maryland, or Towson University).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Currently enrolled at one of the following institutions:

               -  Johns Hopkins University

               -  University of Maryland

               -  Towson University

        PATIENT CHARACTERISTICS:

          -  Able to understand the procedures and the potential risks involved as determined by
             clinic staff

        PRIOR CONCURRENT THERAPY:

          -  No prior Gardasil® off label
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maura Gillison, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins</affiliation>
  </overall_official>
  <link>
    <url>http://cancer.gov/clinicaltrials</url>
    <description>Clinical trial summary from the National Cancer Institute's PDQ® database</description>
  </link>
  <results_reference>
    <citation>Gillison ML. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008 Oct;43(4 Suppl):S52-60. doi: 10.1016/j.jadohealth.2008.07.002. Review.</citation>
    <PMID>18809146</PMID>
  </results_reference>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>May 9, 2009</study_first_submitted>
  <study_first_submitted_qc>May 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2009</study_first_posted>
  <last_update_submitted>January 15, 2019</last_update_submitted>
  <last_update_submitted_qc>January 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recurrent squamous cell carcinoma of the oropharynx</keyword>
  <keyword>oropharyngeal cancer</keyword>
  <keyword>oropharyngeal squamous cell carcinoma</keyword>
  <keyword>infection</keyword>
  <keyword>precancerous condition</keyword>
  <keyword>human papilloma virus infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

